Investors / Neovate Capital Partners
Neovate Capital Partners
Venture capital
Neovate Capital Partners is an early-stage life sciences investment firm that invests in transformational medical devices and therapeutics. The firm draws on partners with operating and clinical experience in MedTech to support portfolio companies through strategy, commercial scaling, team building, financing, and exit planning.
Invests inHealthcare & Biotech
In its own wordslife sciencesmedical devicestherapeuticsmedtechroboticsneuromodulation
Your fit with Neovate Capital Partners
Three questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsNeovate Capital Partners lists 16 companies on its own site. It is named in 3 funding rounds. Its most frequent entry is Seed, 50% of the 2 companies where the round it came in at is known. Its largest theme is Healthcare & Biotech (100%). 92% of its 12 companies with a known country are based in United States. It shares the most portfolio companies with Mountain State Capital, Connecticut Innovations and Creative Destruction Lab.
Counts come from funding rounds that name Neovate Capital Partners, complete from mid-2025: earlier rounds appear only when they were reported later. Reports often leave out co-leads, so a firm may have led more rounds than shown. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Neovate Capital Partners' whole history. Rounds on record name 3 companies; its own site lists 16. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage it came in at · n=2Counted only where the round is where it came in: a pre-seed or seed round, or a later round after the company raised without it.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 50% |
| Series A | 50% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 3 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 39th | 16 companies |
| Recent activity | 71st | 3 rounds in 12 months |
| Early stage | 13th | 50% of 2 known entries at pre-seed or seed |
| Evidence | 65th | 6% of companies confirmed by a round |
| Sector focus | 98th | 100% of companies in its largest theme |
| Reach | 32nd | 2 countries, from 12 companies with a known country |
Shares portfolio companies with
firms that back the same companies, not always in the same roundShow as a table
| Share | |
|---|---|
| Mountain State Capital | 6 |
| Connecticut Innovations | 2 |
| Creative Destruction Lab | 2 |
| Gaingels | 2 |
| AAF Management | 1 |
| AMR Action Fund | 1 |
| Accanto Partners | 1 |
| Asimov Ventures | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers16100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its 16 companies with a theme; a company can have twoThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 17% |
Shared portfolio network
firms that back the same companies, and what they share with each otherAll co-investors or Compare portfolios with Mountain State Capital
Compare Neovate Capital Partners head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Team
1 person, as Neovate Capital Partners' own site lists them- Nick Pachuda D.P.M.Partner
Names and roles from this page of its site; VCinfo keeps nothing else about them. Listed here and want to be removed? Write to us.
Recent portfolio activity
when companies last raised with Neovate Capital Partners| Date | Company | Stage |
|---|---|---|
| 3 Nov 2026 | Seed | |
| 21 Jul 2026 | Series A | |
| 18 Jun 2026 | Series A |
Round details for Neovate Capital Partners
Amounts, full round histories and every co-investor in Neovate Capital Partners' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
16 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Avisi Technologies develops a nanotechnology-enabled device to treat open-angle glaucoma | Healthcare & Biotech | Portfolio page | ||
| Caira is inventing advanced joint replacement software, scanning, and precision radar technologies | Healthcare & Biotech | Portfolio page | ||
| DiscGenics develops regenerative therapies that alleviate pain and restore function in patients with degenerative diseases of the spine. | Healthcare & Biotech | Portfolio page | ||
| Discure develops and tests a minimally invasive, implantable device to treat degenerative disc disease and restore function to the spine | Healthcare & Biotech | Portfolio page | ||
| Icarus Medical provides braces for a wide range of use cases and applications | Healthcare & Biotech | Jun 2026Series A | Funding round | |
| Nanochon designs and develops 3D-printed implants to help repair cartilage naturally | Healthcare & Biotech | Portfolio page | ||
| Ocugenix develops therapies for eye diseases such as wet macular degeneration, geographic atrophy, and diabetic retinopathy | Healthcare & Biotech | Portfolio page | ||
| OSSTEC develops and provides biomimetic cementless fixation technology for joint replacement surgery | Healthcare & Biotech | Nov 2026Seed | Funding round | |
| Osteal Therapeutics is a musculoskeletal therapeutics company developing medications for the treatment of orthopedic infections and their consequences. | Healthcare & Biotech | Portfolio page | ||
| Peca Labs develops and manufactures vascular grafts and heart valves using polymeric materials. | Healthcare & Biotech | Portfolio page | ||
| Peptilogics is a surgical therapeutics company that develops a novel anti-biofilm drug to cure and prevent medical device-related infections. | Healthcare & Biotech | Portfolio page | ||
| Phoenix Kinetics is a company that develops medical implants, specifically the NUsurface Implant, for knee preservation and treatment of early knee osteoarthritis. | Healthcare & Biotech | Portfolio page | ||
| The company creates personalized, 3D-printed orthopedic implants for patients. | Healthcare & Biotech | Portfolio page | ||
| RevMedica develops a surgical stapling platform that provides real-time tissue data to surgeons | Healthcare & Biotech | Portfolio page | ||
| Tybr Health develops and sells a gel system for improving post-operative tendon mobility | Healthcare & Biotech | Jul 2026Series A | Page + round | |
| Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company developing innovative therapeutics for pattern hair loss. | Healthcare & Biotech | Portfolio page |
About this data
site last read 17 Nov 2026- Site
- neovate.vc
- Last read
- 17 Nov 2026
- Watching since
- 17 Nov 2026
- Rounds since
- 18 Jun 2026
- Companies checked
- 16
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Neovate Capital Partners' profile as data
Pull Neovate Capital Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/neovate.vc
# also
GET /v1/firms/neovate.vc/portfolio
GET /v1/firms/neovate.vc/coinvestors
GET /v1/firms/neovate.vc/news